2-hydroxythyl méthacrylate, >=99 %, contient de l' hydroquinone monométhylique à 50 ppm comme inhibiteur

Code: 477028-100ml D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

A polymeric hydrogel for drug delivery. Patent has been applied for the development of artificial cornea or KPro, it is composed of pHEMA (polymerized from HEMA) ...


en savoir plus

Votre prix
$76.02 100ML
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

A polymeric hydrogel for drug delivery. Patent has been applied for the development of artificial cornea or KPro, it is composed of pHEMA (polymerized from HEMA) and poly (methyl methacrylate)(PMMA). HEMA may be used as a macromonomer for the synthesis of 2-hydroxyethylmethacrylate-poly(ε-caprolactone) (HEMA-PCL) by coordinated anionic ring opening polymerization (ROP).

General description

2-Hydroxyethyl methacrylate (HEMA) is biocompatible in nature. Polymeric hydrogel scaffold can be produced by polymerizing HEMA in water.

Packaging

25, 100 mL in poly bottle

assay≥99%
bp67 °C/3.5 mmHg (lit.)
contains≤50 ppm monomethyl ether hydroquinone as inhibitor
density1.073 g/mL at 25 °C (lit.)
InChI keyWOBHKFSMXKNTIM-UHFFFAOYSA-N
InChI1S/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3
Quality Level200
refractive indexn20/D 1.453 (lit.)
SMILES stringCC(=C)C(=O)OCCO
storage temp.2-8°C
vapor density5 (vs air)
vapor pressure0.01 mmHg ( 25 °C)
Code
Description
Unité de vente
Prix annoncé
Qté
477028-25ML
2-hydroxythyl méthacrylate, >=99 %, contient de l' hydroquinone monométhylique à 50 ppm comme inhibiteur

Unité:25ML
Prix annoncé: $67.51
Source:Prix annoncé
AJOUTER
Cas Number868-77-9
Ce produit répond aux critères suivants: